c.1 BC Cancer Agency VAN Library REF | Available |
Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions; Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions; Guidelines on the use of intravenous immune globulin for hematologic conditions; Guidelines…
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
This report focuses on investment in research focused on cancer risk and prevention over a three-year period. Research is critiical to our understanding of cancer risk and effective cancer prevention strategies. The investment in cancer risk and prevention at $122.3M represented 11% of the overal…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
v.31 no.4 BC Cancer Agency KEL Library Journals | Available | ||
BC Cancer Agency KEL Library Journals | Available | ||
v.31 no.2 BC Cancer Agency KEL Library Journals | Available | ||
v.31 no.3 BC Cancer Agency KEL Library Journals | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |